evitria
Antibodies Journal
News
Engineering bispecific antibodies

Share this article:

Join our newsletter to stay up-to-date with the latest insights in biotechnology!

Engineering bispecific antibodies

Recorded Presentation: From mAb to bAb

Developing drugs requires navigating complex technical, practical, and strategic challenges quickly. Optimizing a drug’s activity and effectiveness and subsequently considering the IP landscape are crucially important balancing acts. Here, we demonstrate how evitria’s extensive expertise in antibody production can help you engineer, reformat, and produce your therapeutic, using a case study for the transformation of a mAb into a bsAb.

Engineering bispecific antibodies – video

Speaker

Desmond Schofield, pHD

Learn more

How to choose a bispecific antibody format

Bispecific antibody prod u ction service

bYlok® bispecific pairing technology in bsAb production

Share this article:

Join our newsletter to stay up-to-date with the latest insights in biotechnology!

Further readings about News

News

AAX Biotech and evitria to expand access to Opti-mAb® technology in early antibody development

STOCKHOLM / 23 April 2026 – Biotech company AAX Biotech, a leading innovator in technologies for antibody-based therapies, today announced a partnership with evitria AG, an expert provider of antibody engineering and expression services, to enable the use of its Opti-mAb® technology in early antibody development workflows. AAX Biotech develops proprietary technologies, including Opti-mAb®, supporting […]
News

Bengt Thorsson and Johan Rockberg to join Atlas Antibodies’ Board of Directors

We are pleased to announce the election of Bengt Thorsson and Johan Rockberg to Atlas Antibodies’ Board of Directors, following the AGM on May 23, 2025. Åsa Riisberg has been re-elected as Chair of the Board and Catarina Flyborg, Gavin Wood, Christian Eberle and Louise Kores have been re-elected as board members. We thank Mathias […]
News

Press release: evitria Celebrates 15 Years with Exclusive Giveaway for Industry Experts

Tickets for Festival of Biologics, Networking Dinner, and Exclusive Tour of evitria AG in Zürich Up for Grabs Zurich, Switzerland – March 2025 – evitria, a leading provider of antibody development services, is celebrating its 15th anniversary with an exciting giveaway that offers an exclusive opportunity to attend the Festival of Biologics in Basel, Switzerland. […]
News

Engineering bispecific antibodies

Recorded Presentation: From mAb to bAb Developing drugs requires navigating complex technical, practical, and strategic challenges quickly. Optimizing a drug’s activity and effectiveness and subsequently considering the IP landscape are crucially important balancing acts. Here, we demonstrate how evitria’s extensive expertise in antibody production can help you engineer, reformat, and produce your therapeutic, using a […]
News

evitria and Lonza Sign License Agreement to Provide Fast Access to bYlok® Bispecific Antibodies for Discovery-Stage Transient Expression Research

Zurich-based evitria AG has entered a non-exclusive license agreement with Lonza for its bYlok® technology, enabling simple and reliable development of IgG-like bispecific antibodies.
Antibodies

Bespoke solutions for lead selection and optimization in cancer antibody research

In this Webinar, Richard Park from evitria, will present Case Studies on Flexibility: Bespoke Solutions for Lead Selection & Optimization in Cancer Antibody Research – get your video now!

Engineering bispecific antibodies

Speaker

Learn more

Read more from Team evitria

AAX Biotech and evitria to expand access to Opti-mAb® technology in early antibody development

Polyclonal Antibody Production: A Comprehensive Guide

Differences between monoclonal antibodies and recombinant monoclonal antibodies

Further readings about News

AAX Biotech and evitria to expand access to Opti-mAb® technology in early antibody development

Bengt Thorsson and Johan Rockberg to join Atlas Antibodies’ Board of Directors

Press release: evitria Celebrates 15 Years with Exclusive Giveaway for Industry Experts